The pill of gender bias – hard to swallow

(Credit: Unsplash)

This article was exclusively written for The European Sting by Ms. Manali Sarkar, a 2nd year MBSS student at MGM Medical College, Navi Mumbai. She is affiliated to the International Federation of Medical Students Associations (IFMSA), cordial partner of The Sting. The opinions expressed in this piece belong strictly to the writer and do not necessarily reflect IFMSA’s view on the topic, nor The European Sting’s one.

Medicine has not taken the intricacies of the female body into account – and so “women’s health” became synonymous with reproductive organs. It was only during the 21st century that such obsolete ideas were challenged by the emergence of evidence that women experience heart attacks differently than men. The difference comes right down to the cellular levels. Research published by Israel’s Weizmann Institute of Science in 2017 found that around a third of the 20,000 genes present in a cell express themselves differently in males and females[1]. Yet, why is the unique physiology of a woman not taken into consideration? How can we as medical students change this?

One way is using an equal number of male and female mice during research. Among 1200 neuroscience papers from 2011 and 2012, only 42% reported the sex of the mice used of which only 24% were female[2]. Secondly, we need a gender specific approach to any treatment procedure. Kautzky-Willer’s research specializes in diabetes and she has found that women usually have a lower fasting glucose and HbA1C than men. She hypothesizes that a separate blood test with different cutoffs or biomarkers will be needed to diagnose diabetes in men and women[3]. Similar conclusions are occurring in varying fields of medicine; for example, women are more sensitive to antihistaminic drugs and aspirin is more effective in stroke prevention in woman but heart attacks in males etc[4].

Unfortunately, findings such as these have not had widespread impact on diagnosis and treatment. A vast majority of diagnoses, therapies and drug dosages for common conditions are still based on symptoms, responses and outcomes in Caucasian adult males.  Berga says that there are two things going on at once- “One is the urge to simplify to make things efficient, to arrive at something that’s one size fit all. The other is that if something does not work in one size fits all model, then you have to find the reason and determine what should be changed, and you run into questions about how much it will cost to do this, how long it will take and so on” [5].

The “one size fits all” theory can be disproven by having an inclusive list of participants. A 2010 study from the Duke Clinical Research Institute in the USA found that only a quarter of those involved in coronary artery disease trials are women [6]. Shockingly enough the study to demonstrate alcohol interaction with Flibanserin (a drug which was passed by the FDA for treatment of hypoactive sexual desire disorder in premenopausal women) enrolled 23 men and 2 women and thus many researchers like Dr. Mazure expressed concern over the nature of the study [7]. Medical students should also acknowledge the limitations of medicine with respect to women instead of dismissing them as “hysterical” and invalidating their negative experiences. Dr.Young reports of how women who were ineffectively treated by current medication of endometriosis were labeled as “difficult” [8].

Thankfully not all hope is lost. In 2013, the FDA applied new recommendations for lowering the dosage of drugs containing active ingredient Zolpidem[9]. In 2016 the NIH began to mandate that research should include female animals [10].

[1] Pietrokovski, Shmuel and Gershoni, Moran. “Differences in male vs. female gene expression drive infertility,” Weizmann Compass, 2017.

[2] Rozenbaum, Mia. “Why we need female mice in drug trials,” Understanding Animal Research, 2019.

[3] Crompton, Simon. “Should medicine be gendered,” BBC Science Focus Magazine, 2019.

[4] Soldin, Offie P., Chung, Sarah H., and Mattison, Donald R. “Sex Differences in Drug Disposition,” Journal of Biomedicine and Biotechnology, 2011.

[5] “Medicine Looking Deeper Into Vital Differences Between Women and Men,” Wake Forest Baptist Health. Date accessed: Sept. 27 2020.

[6] Shen, Lan and Melloni, Chiara. “Representation of Women in Randomized Clinical Trials of Cardiovascular Disease Prevention,” ,2014.

[7] Harrison, Rick. “Safety of Drinking with New Female Libido Drug Tested in Mostly Men”

Yale Medicine, 2015.

[8] Young, Kate, Fisher, Jane and Kirkman, Maggie. “Do mad people get endo or does endo make you mad? Clinicians’ discursive constructions of Medicine and women with endometriosis,” Feminism and Psychology, 2018.

[9] Tavernise, Sabrina. “Drug agency recommends lower dose of sleep aids for women”, The New York Times, 2013

[10] Jackson, Gabrielle. “The female problem: how male bias in medical trials ruined women’s health,” Guardian, 2019.

About the author

Manali Sarkar is a 2nd year MBSS student at MGM Medical College,Navi Mumbai. As a volunteer for MSAI, she had the opportunity to talk to various people (patient and healthcare professionals included) who would discuss such sensitive issues and the response among them would widely differ. Hence to highlight these varied responses and encourage a healthy debate among people of various nations, age, gender and race she has submitted this article to IFMSA

the sting Milestone

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

From the Field: Women push for peace

Why medical students decide to study abroad?

As children in Ebola-affected areas of DR Congo head back to school, UNICEF ramps up support

Human rights breaches in Azerbaijan and Sudan

European Citizens’ Initiative: Commission registers ‘End the Cage Age’ initiative

New malaria vaccine trial in Malawi marks ‘an innovation milestone’, declares UN health agency

UN chief hopes for new agreement after Israel concludes international observation mission

UN chief urges top digital tech panel to come up with ‘bold, innovative ideas’ for an ‘inclusive’ future

Coronavirus: The truth against the myths

UN chief praises Malaysia’s death penalty repeal as ‘major step forward’

Mental health in the COVID-19 pandemic

Asylum seekers in Sri Lanka fear for their safety, in wake of Easter Sunday terror attacks

These 8 countries have perfect scores for women’s rights at work

Some 300,000 Venezuelan children in Colombia need humanitarian assistance; UNICEF looks to boost response funding

Yemen war: UN-backed talks to silence the guns due to begin in Stockholm

Why embracing human rights will ensure Artificial Intelligence works for all

4 ways digitisation can unlock Africa’s recovery

European Commission reacts to the US restrictions on steel and aluminium affecting the EU

This is how we can empower 8 billion minds by 2030

World Health Organisation and young doctors: is there any place for improvement?

This is why people live, work and stay in a growing city

A Sting Exclusive: “Technology for all, development for all: the role of ITU”, written by the Secretary General of the United Nations Agency

Τhe EU Refugee Crisis: a day in the life of a Refugee in Greece

EU budget agreement rejected by the European Parliament

Global Compact on Refugees: How is this different from the migrants’ pact and how will it help?

EU–Canada Summit: strengthening the rules-based international order

Africa’s future is innovation rather than industrialization

Living in the mouth of the shark: we are all refugees

Trump systematically upsets global order and trade: Where does this end?

Upgraded EU visa information database to increase security at external borders

Two-thirds of global drug deaths now from opioids: UN drugs report

Global aid appeal targets more than 93 million most in need next year

Health services for Syrian women caught up in war, foster safety and hope: UNFPA

How to push out of our comfort zones – an extract

Climate change: ‘A moral, ethical and economic imperative’ to slow global warming say UN leaders, calling for more action

Subsidiarity and Proportionality: Task Force presents recommendations on a new way of working to President Juncker

How Costa Rica’s environment minister talks to his daughter about climate change

Trump rejects Europe’s offer for zero car tariffs; he had personally tabled that idea in July

A Sting Exclusive: “Cybersecurity Act for a cyber-bulletproof EU”, by EU Vice-President Ansip

Ukraine turns again to the EU for more money

European Citizens’ Initiative: Commission registers ‘Stop Finning – Stop the trade’ initiative

‘Eden bonds’: how rewilding could save the climate and your pension

OECD tells Eurozone to prepare its banks for a tsunami coming from developing countries

What if the doctor become a patient?

What’s going on in Chernobyl today?

Tackling ‘deeply worrying’ global rise in anti-Semitism is a job for all societies everywhere, says UN chief

These are the world’s least – and most – corrupt countries

Time to measure up: 5 ways the fashion industry can be made more sustainable

Refugee crisis update: EU fails to relocate immigrants from Greece and Italy

Belgium eases lockdown with free train tickets for every citizen

Trade Barriers Report: EU continues to open up markets outside Europe in midst of rising protectionism

One-third of young people still optimistic despite COVID’s dramatic hit on education and jobs

Customs Union: New Action Plan to further support EU customs in their vital role of protecting EU revenues, prosperity and security

5 things you probably didn’t know about global health

How video games can reunite a divided world

Managing and resolving conflicts in a politically inclined group of team members

Sri Lankan authorities must work ‘vigorously’ to ease simmering ethno-religious tensions, urges UN rights expert

COP25: Support business efforts to tackle climate change, urges Guterres

Cohesion Policy after 2020: preparing the future of EU investments in health

Time to act together: Von der Leyen at the European Parliament July plenary

More Stings?


Speak your Mind Here

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s